📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Athersys

1.1 - Company Overview

Athersys Logo

Athersys

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of an adult-derived, off-the-shelf stem cell therapy platform, MultiStem, for neurological, inflammatory and immune, cardiovascular, and other critical care indications. Conducts clinical trials and programs including MASTERS-2 and TREASURE for stroke, and AMI, PVD, and congestive heart failure.

Products and services

  • MASTERS-2: A Phase 3 clinical trial primarily in North America and Europe evaluating the efficacy of MultiStem cell therapy for treating ischemic stroke
  • MultiStem: A patented, adult-derived off-the-shelf stem cell therapy platform developed to treat neurological, inflammatory and immune, and cardiovascular diseases, plus other critical care indications
  • TREASURE trial: A clinical study in Japan conducted under Japan’s regulatory framework for regenerative medicine therapies assessing the safety and effectiveness of MultiStem for stroke patients

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Athersys

NPS Pharmaceuticals Logo

NPS Pharmaceuticals

HQ: United States Website
  • Description: Provider of therapies for rare diseases, dedicated to making a difference in the lives of patients who often have few, if any, treatment options.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full NPS Pharmaceuticals company profile →
Rejuveron Logo

Rejuveron

HQ: Switzerland Website
  • Description: Provider of a fully integrated biotechnology platform that invests in people and ideas to develop therapies and technologies to improve healthy aging and prolong lifespan.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Rejuveron company profile →
Pieris Pharmaceuticals Logo

Pieris Pharmaceuticals

HQ: United States Website
  • Description: Provider of clinical-stage immuno-oncology biotechnology programs, including 4-1BB bispecific programs developed with Pfizer, Servier, and Boston Pharmaceuticals, and potential future partnership royalties from sales of approved partnered immuno-oncology assets.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Pieris Pharmaceuticals company profile →
Perrigo Logo

Perrigo

HQ: Ireland Website
  • Description: Provider of a variety of over-the-counter and generic prescription pharmaceuticals as a pharmaceutical and consumer goods company.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Perrigo company profile →
Novo Nordisk Logo

Novo Nordisk

HQ: Denmark Website
  • Description: Provider of insulin and other diabetes drugs for chronic diseases, GLP-1 treatments for type 2 diabetes, obesity care pharmaceuticals, Mim8 for haemophilia A (weekly or monthly dosing), and ReMed, a recycling program for used injection pens, with a focus on pioneering scientific breakthroughs and expanding access to medicines to prevent and cure disease.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Novo Nordisk company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Athersys

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Athersys

2.2 - Growth funds investing in similar companies to Athersys

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Athersys

4.2 - Public trading comparable groups for Athersys

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Athersys

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Athersys

What does Athersys do?

Athersys is a provider of an adult-derived, off-the-shelf stem cell therapy platform, MultiStem, for neurological, inflammatory and immune, cardiovascular, and other critical care indications. Conducts clinical trials and programs including MASTERS-2 and TREASURE for stroke, and AMI, PVD, and congestive heart failure.

Who are Athersys's competitors?

Athersys's competitors and similar companies include NPS Pharmaceuticals, Rejuveron, Pieris Pharmaceuticals, Perrigo, and Novo Nordisk.

Where is Athersys headquartered?

Athersys is headquartered in United States.

How many employees does Athersys have?

Athersys has 1,000 employees 🔒.

When was Athersys founded?

Athersys was founded in 2010 🔒.

What sector and industry vertical is Athersys in?

Athersys is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Athersys

Who are the top strategic acquirers in Athersys's sector and industry

Top strategic M&A buyers and acquirers in Athersys's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Athersys?

Top strategic M&A buyers groups and sectors for Athersys include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Athersys's sector and industry vertical

Which are the top PE firms investing in Athersys's sector and industry vertical?

Top PE firms investing in Athersys's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Athersys's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Athersys's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Athersys's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Athersys include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Athersys's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Athersys?

The key public trading comparables and valuation benchmarks for Athersys include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Athersys for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Athersys with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Athersys's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Athersys with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Athersys's' sector and industry vertical?

Access recent funding rounds and capital raises in Athersys's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Athersys